TIS 0.00% 0.0¢ tissue therapies limited

Ann: VitroGro Sales Planned to Start in June 2012, page-25

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 375 Posts.
    re: Ann: VitroGro Sales Planned to Start in J... Hi Jer,

    I sold out this morning. We were all sitting back expecting an EU approval announcement and then they tell us that it has only just been lodged. What the ...

    Yes, I,m all for the product and hope to be able to reaccumulate in 30's like recently, if I miss out still think there will be opportunities approaching EU approval in next 40 days or to re-enter once approved but initial excitement dies down (obviously at a higher price then).

    What was the bit about data for the FDA? I thought they were planning on starting a trial over there? What happenned to that.

    Anyway, I'm out for the moment - I would have much rather incurred the cost of making more vitrogro with the certainty of approval - surely this is just the spin they've put on it.

    Re the cost to produce - I disgree that this shows it's more expensive to produce - I read this as the cost of relabelling outweighs the cost to produce more suggesting the cost to produce product is actuall quite low.

    just my musings.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.